Biorasi Partners with RLH Equity to Spur Expansion and Growth
December 11, 2018 08:00 ET
|
Biorasi
Miami, FL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Biorasi, a leading full-service global contract research organization (CRO), is excited to announce that it has successfully closed an investment...
BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018 11:48 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...
TikaMobile Announces Business Intelligence CRM Solution for Market Access Teams to Increase Coverage and Pull-through Performance of Sales Teams
December 06, 2018 08:30 ET
|
TikaMobile, Inc.
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- TikaMobile, the premier leader in cloud-based business intelligence and CRM software for the global life sciences industry, announces the latest...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 05, 2018 23:19 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 20/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 06 December 2018 Veloxis Increases Share Capital in Connection with...
University of Notre Dame and Indiana Biosciences Research Institute partner to address health concerns
December 05, 2018 13:04 ET
|
Indiana Biosciences Research Institute
NOTRE DAME, Ind., Dec. 05, 2018 (GLOBE NEWSWIRE) -- The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage...
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2018
November 14, 2018 13:54 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 19/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 14 November 2018 Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2018 ...
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
October 31, 2018 14:21 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 18/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 October 2018 Ira Duarte Promoted to Chief Financial Officer...
Incysus Therapeutics to Participate in Panel at the 2018 Life Sciences Summit
October 22, 2018 08:00 ET
|
Incysus Therapeutics, Inc.
Panel Title: “Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies” NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company...
Surgical Simulation Market to Reach $608.3 Million by 2023: P&S Intelligence
October 22, 2018 03:30 ET
|
Prescient & Strategic Intelligence
Surgical Simulation Market by Offering (Products [Laparoscopic, Endoscopic, Neurological, Gynecological, Cardiac, Arthroscopic], Services [Educational, Technical]), by End User (Academic &...
Veloxis to Present at Jefferies 2018 London Healthcare Conference
October 10, 2018 17:13 ET
|
Veloxis Pharmaceuticals A/S
Investor News no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 10 October 2018 Veloxis to Present at the Jefferies 2018 London Healthcare...